The Debate is Launched!
Wakefield's first publication in 1998 (8) reported a consecutive series of 12 patients presenting with a loss of acquired language associated with diarrhea and abdominal pain. Thorough, multisystem investigation demonstrated no definitive abnormalities other than nonspecific colitis and ileal-lymphoid-nodular hyperplasia that was found in 9 of the children. Parents reported gastrointestinal (GI) symptoms for these children starting soon after their MMR vaccination.
Wakefield suggested that these findings were likely initiated by an environmental trigger, although initially did not make the direct link with the vaccine. Instead, he merely commented on his theory of a link between GI inflammation and measles virus and the temporal association of MMR with autism. In Wakefield's subsequent communication to the American Academy of Pediatrics (AAP) committee, (9) he proposed that associated changes in intestinal permeability and altered peptidase activity allow neurotoxic intestinal products (e.g., exorphins) to reach the brain, which is particularly susceptible to permanent damage during times of rapid cerebral development in infancy. He added, " In susceptible children (possibly for reasons of age, immune status, or genetic background) MMR vaccine is an atypical pattern of measles exposure that represents a significantly increased risk for intestinal infection and associated developmental regression
Immunization and Children at Risk for Autism compared with the monovalent vaccine, or natural infection. Accordingly, the widespread use of MMR immunization is a major determinant of the apparent increase in rates of autism." The sentiment of this statement continues to be delivered by Dr. Wakefield to parents in autism meetings around the world. A survey at the Autism Society of America in 2000 indicated that more than 50% of parents present felt that vaccines were the main causal factor in their child's autism (9).
Wakefield's arguments focus on 3 areas that raise vaccination anxiety:
1)
Abnormal GI tract
2) Impaired immune status
3) Monovalent vaccine use
1) Measles and "Leaky Gut"
Wakefield et al claim that autism is the result of GI abnormality, yet autistic symptoms predated reported GI disturbance. Since no control group existed, the reported ileonodular hyperplasia is considered a variant of normal. Leaky gut hypotheses (10, 11, 12, 13) have suggested that differences in gut permeability lead to opioid excess and thus neuropsychiatric abnormalities, as well as causing malabsorption and metabolic abnormalities such as methylmalonic aciduria.
Although D'Eufemia has also discussed leaky guts in autism (14) , there is as yet no further data to support the impact of leaky gut on behavioural abnormalities. Neither is there evidence for
Wakefield's previous claims about measles link to Inflammatory Bowel Disease (IBD) (15) that caused years of concern for that population until failure of replication refuted his claims (16) .
There are conflicting reports of measles virus nucleocapsid RNA being present in intestinal tissue in individuals with autism and IBD. Measles nucleocapsid RNA has also been found in
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There is, on the other hand, some evidence that gastrointestinal problems exist in autism.
Horvath (19) has described chronic inflammation in the esophagus, stomach and duodenum of children with chronic diarrhea, reflux and autism. Kagan-Kushnir (20) found an increased incidence of reflux and diarrhea in children with autism compared to non-affected siblings.
Taylor et al (21) in his recent report in the British Medical Journal (BMJ) reported significant gastrointestinal problems in children with autism, apparently more likely in the regressive type.
These gastrointestinal problems were not more frequent in the group who received MMR compared to the group who did not receive MMR before its introduction in 1988. The connection between these gastrointestinal abnormalities and behavioural symptoms needs more exploration but does not appear to be related to immunization.
2) Is immune function in autism conferring vulnerability to vaccine?
A number of studies have suggested underlying immunologic abnormalities in autism ranging from decreased cellular immune function, increased immunoglobulin E and increased autoantibody production (9). Singh and Fudenberg (22) as well as Gupta (23) suggested that immune abnormalities in autism could cause vulnerability to MMR vaccine and precipitate autistic regression. They described a genetic association with autism linked to a null allele of the complementC4b gene in the Class III region of the Major Histocompatibility Complex. Evidence
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3) Monovalent vs.Trivalent Vaccines
Wakefield suggested that monovalent vaccines may pose less challenge to the vulnerable immune system (9) although no data exist to support this hypothesis. Since the majority of vaccine safety data relates to MMR, it is difficult to find evidence relating to the questions: Is it physiologically more natural to spread out exposure to antigens? If there is a qualitative difference in immune status, is there increased risk from more than one antigen exposure at a time?
In fact, children are often exposed in nature to more than one wild virus in a short period of time in winter and spring. An early study comparing reactions to monovalent measles vaccine vs. MMR reported fewer side effects from MMR than from univalent measles (25) . Since MMR was introduced so soon after the measles vaccines became available, little safety data exists for the monovalent vaccines. In addition, some may not be as effective (26) . Although not available in Canada, some parents are getting the monovalent measles vaccine from the United States.
Precise Canadian numbers do not exist, but the Medicines Control Agency in Britain reports importing 8,000 monovalent measles vaccine doses in 2001 compared to 900 in 2000.
The biggest risk in the use of monovalent measles vaccine is the delay in protection for rubella and mumps, since 6 needles will be required over an unspecified period of time. Some parents do proceed with MMR after children have passed 2 or 3 years of age when their fear of autistic regression has diminished.
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Evidence to Refute Wakefield's Claims about Autism and MMR
The strong evidence for the lack of association of MMR and autism is contained in the very comprehensive AAP Report (9) and in the Canadian Paediatric Society (CPS) Statement, August 2001 (27) . Taylor and Kaye (21, 28, 29) in England have some of the most convincing evidence:
The increased rate of reporting of autism to the General Practice Research database was not effected by MMR.
•
• •
A nearly 4-fold increase in the incidence of autism occurred in 2-5 year old boys born between 1988-93, while the uptake of MMR stayed constant at 95%.
Incidence and age of diagnosis of autism was the same in vaccinated and unvaccinated children.
The rate of regressive autism in the U.K. was similar pre-and post-MMR introduction in 1988. Fombonne published a similar review of pre-and post-MMR data in which he found no change in regression rate or age of onset of parental concerns (30) . Similarly, in California, Dales (31) reported that the increase in reports of children receiving services for ASD occurred in the late 1980's and 1990's long after the MMR vaccine was introduced in the United States. In Sweden, ecological data of Gillberg and Hejbell (32) showed rates of autism that did not change with MMR introduction in the 80's.
Side Effect Data
Peltola in Finland (33, 34) documented 31 children with transient gastrointestinal symptoms in the first 4 weeks after MMR, five of whom also had febrile seizures. Most symptoms resolved in one week, and all in 6 weeks. Peltola reported no cases of autism in a 14-year prospective follow-up of 3 million vaccinations through hospital, health centre and public health nurse
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-9 -records. While Peltola has strong short-term safety data, it is unclear why no cases of autism were reported in 14 years. Conservative estimates based on population incidence would suggest several hundred children would have autism in over one million children being followed.
Nonetheless, this study contains the best evidence of overall safety of MMR.
Physician's Role
As covered in the handout for parents included with this article, there are key discussion points that may help concerned parents:
Autism is thought primarily to originate from prenatal injury. There is a 1/1000 risk of a wild measles virus infection causing encephalitis and/or death compared to 1/100,000 risk of severe adverse reaction to immunization (35) .
There are dozens of reported cases of wild measles infections every year in Canada (36, 37) and the numbers in England are rising as immunization uptake decreases.
Data collected in Colorado between 1987 and 1998 clearly shows that unimmunized children between 3 and 5 years of age are 66 times more likely to acquire measles infection than are their immunized peers (38) . This number will increase if more parents fail to immunize their children.
There is no evidence that the younger sibling of an affected child (even one with regressive autism) is more likely to regress if the first sibling regressed.
The percentage of regressive autism has not changed pre-and post-MMR use (30) .
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There is no evidence that children with autism have more severe reactions to wild measles infections.
• • If immune status is different in autism, wild virus infection will pose a much greater threat to a young child than will a vaccination.
The traditional medical world is perceived as unwilling to listen to questions from parents, therefore when physicians such as Wakefield raise controversial hypotheses to the general public they can become very popular and bring dangerous credence to unproven hypotheses. Once claims are made about vaccinations, as with therapies such as secretin three years ago (39), the inevitable delay in collecting evidence to refute the claims creates periods of time during which worried parents feel they do not have the information needed to make informed decisions.
Caution from physicians in the interim (e.g. "You must immunize!"), may be seen as typical of the conservative and defensive medical system and may antagonize rather than convince some members of the general public. Listening to parents and presenting the evidence for safety as well as the risks of delay in vaccinating are still the most effective strategies. Mercury derived from thimerosal (used as a preservative) has also received a great deal of attention on the Internet and through litigation proceedings against companies producing vaccines in the U.S. This has served to heighten parents' concerns regarding vaccine safety, particularly for children seen as particularly vulnerable. If, as suggested, mercury in vaccines contributes to autism, one would then expect Canadian incidence figures for autism to be lower than international figures. In fact, Nova Scotia data from the 1980's and anecdotal data from physicians' practices in Canada are quite comparable to that reported in other countries (1, 42) .
Title: IMMUNIZATION AND CHILDREN AT RISK FOR AUTISM
What is known about mercury and developmental disorders?
Thimerosal is metabolized to ethylmercury that is felt to have similar effects to methylmercury.
Apart from recognized delayed sensitivity reactions, high dose exposure is known to include neurotoxicity and nephrotoxicity. Chronic low dose exposure may cause subtle neurologic abnormalities. Weir (43) the Seychelles study reported no correlation between mercury levels and developmental problems, whereas Grandjean (47) in the Faroe Islands suggested detectable neuropsychologic abnormality in 7-year-olds whose mothers consumed pilot whale meat, by measuring mercury levels in maternal hair samples and cord blood. Dysfunction in language, attention and memory was suggested but no symptom specifically resembled autism. Further analysis is ongoing since all the effects were small, but maternal ingestion of mercury appears to be the most significant factor for young children.
As a result of Ball's review and an independent review by the Institute of Medicine (IOM) (48), the following conclusions regarding mercury and vaccines have been reached:
• Low dose thimerosal exposure in humans has not been demonstrated to be associated with effects on the nervous system.
• Thimerosal exposure from vaccines has not been proven to result in mercury levels associated with toxic response.
• Signs and symptoms of mercury poisoning are not identical to autism, ADHD, or speech / language delay.
• There is no evidence that ethylmercury causes any of the pathophysiological changes known to be associated with autism (e.g., genetic defects).
Unique Concerns for Parents with Children at Risk for Autism:
Metallothionein and Chelator Use Because of Mercury in Vaccines
Walsh from the Pfeiffer institute presented a study to the American Psychiatric Association • Mercury stays in the body for a brief time: 12 weeks. This is unlike lead, arsenic and other metals.
• DMSA does not cross the blood-brain barrier.
• Chelation is an invasive treatment that may effect liver, bone marrow and renal function and may cause allergy and loss of essential nutrients (such as zinc and others) that may not be replaced by taking food supplements.
• Apart from directly causing adverse behavioral effects, chelation (depending on the chelator, the dose and the metal being chelated) can result in changes in the toxicokinetics that can
Immunization and Children at Risk for Autism
lead to increased concentrations of the toxin in the central nervous system causing greater neurodevelopmental injury.
• Chelation has minimal effect on methylmercury and has not been shown to reverse neurologic injury from any type of metal poisoning.
Current Research
Although it is too late for parents making current decisions about siblings' vaccinations, the NIH is now responding to parents' concerns. Their internet website (www.nichd.nih.gov) contains excellent information for parents and outlines initiatives underway:
• Research is being done to compare classic autism (since birth) versus autism after regression.
Vaccination records are being studied to see if autism onset was related to MMR or other vaccines; signs of persistent infection related to MMR will be sought.
• Environmental effects (pollutants and vaccines) on child health will be studied by following 100,000 children.
Conclusions
Definite evidence exists for the safety of vaccinations currently being given to Canadian children. All possible efforts must be made to protect children from devastating infectious diseases.
Listening to parents, understanding their concerns, and helping them to evaluate the evidence regarding the rapid media presentation of "quick fixes" is a time-consuming and sometimes difficult process for the physician. Too rapid denunciation of parental concerns leads to loss of trust in the public health system. Everyone may suffer as a result.
Scientists need to be encouraged to undertake controversial research without fear of vilification by colleagues; at the same time, caution is needed to avoid raising the profile of questionable hypotheses while studies are being conducted.
It is essential to have ongoing studies into vaccination risks for special subgroups of children (such as siblings of children with autism) whose potentially unique responses may be lost in large group data. While reassuring data exists, vulnerability to measles or heavy metals for children genetically susceptible to autism has not yet been unequivocally ruled out. Evidence that early signs of autism present in infancy before obvious regression noted by parents may change the perception of onset being related to vaccines, and reinforce the genetic bases of the disorder.
Failing to immunize constitutes a well-known and extremely high risk for all children.
This is particularly the case for families with a history of autism if there is any increased vulnerability to infection or toxins. As parents wait for results of studies currently underway, physicians need to keep reinforcing the evidence and the known risks from overwhelming infectious diseases. They must encourage parents to protect all their children through vaccination.
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VACCINATION AND AUTISM SPECTRUM DISORDER (ASD): A GUIDE FOR PARENTS
Possible connections between autistic disorders and immunizations have recently been the subject of a great deal of debate, and have understandably caused much concern for parents who want to make the safest choices for their children. This guide is intended to help parents understand the controversy and make informed choices.
Medical science has not yet solved the mystery of autism. There is still no blood test or procedure that can identify children on the autism spectrum. We believe the cause is genetic and that autism starts soon after conception, in the first three months of fetal life. Studying videos of children in their first year of life who later received a diagnosis of autism has helped us to see some early signs of the disorder that had not been noticed before. For example, babies who may eventually be diagnosed with autism tend to be less interactive, more interested in objects than in people, and are either more passive or more irritable than other babies of the same age. Ongoing research continues to increase our understanding of the complexities of ASD.
Is the number of children with autism increasing?
No good evidence exists to show us that more children have autism now than in years past.
Experts agree that what seems to be a higher number of children with autism are actually more children being identified and receiving a diagnosis of autism spectrum disorder. Why?
More professionals are being trained to recognize early symptoms of ASD. •
• •
In the past, autism was narrowly defined, with only the most severely affected children receiving the diagnosis.
We now know that autism exists on a broad spectrum that includes children who are mildly affected, children with severe symptoms, and many levels of autism symptoms affecting
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Children with autism who may previously have been misdiagnosed with another disorder are now being correctly identified.
• • In short, a larger number of knowledgeable professionals are identifying autism spectrum disorder in more children and at an earlier age.
Of course, other factors that may influence the number of children diagnosed with autism have not been entirely ruled out. For example, research continues into the possibility that environmental toxins (e.g., pesticides, heavy metals) may cause genetic changes that affect the development of the immature fetal brain, leading to a variety of neurological problems. We do not have all the answers yet.
Part 1: MEASLES-MUMPS-RUBELLA (MMR) VACCINATIONS
Why was MMR vaccine ever linked to autism?
Some people have assumed that there are links among autism, changes in child behaviour, and MMR vaccination because the first MMR shot is given very close to the time that we commonly begin to identify autistic symptoms.
Parents typically notice first signs of autism 2 years 3 years Birth
First MMR Vaccine
Research finding subtle early signs of autism.
year
One-third of ASD children show regression (stop using words they had learned) and withdraw from social contact
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The scientific debate began in 1998 with the release of results from a British research study that raised the question of a link between autism and MMR vaccine because of a gastrointestinal problem described as "leaky gut".
Suggestions of a Connection What We Know
Dr. Andrew Wakefield, England, 1998: 
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What do we know for sure?
There is no reliable evidence that measles causes a "leaky gut" which can release toxins that reach the brain to cause neurological disorders.
The increase in reported cases of autism spectrum disorder has not been proven to be associated with MMR vaccination.
The rate of autistic regression since MMR vaccine was introduced is similar to the rate of regression before the vaccine was available.
Rates of reported autism have risen while the number of children receiving MMR has not changed from an average of 95%.
The percentage of children with autism is the same in vaccinated and unvaccinated populations.
Some studies have suggested that autistic children have abnormalities in their immune systems, however, there is no evidence that ASD children get sick more often, or that they do not fight infection as well as other children.
I already have one autistic child. My second child seems normal at 12 months -how likely is it that he will show signs of autism in the next year?
• The overall risk of having a second child with ASD is between 5 and 8%.
• There is no current evidence that siblings are more likely to have autistic regression because their older brother or sister lost language and social skills around age two.
Should I wait before vaccinating my second child? My Paediatrician says its okay to wait until he is over 2 years old.
Since there is no evidence that the introduction of MMR vaccine increased the number of children with autism, it is unlikely that delaying MMR will make any difference to the risk of your second child developing ASD.
What evidence is there that MMR vaccine is safe?
There is strong short-term safety data relating to the study of 3 million vaccinations in Finland:
Only thirty-one children had transient gastrointestinal symptoms during the first four weeks after MMR; five of them also had fever-related seizures.
• Most symptoms resolved in one week, and all resolved in six weeks.
• No cases of subsequent autism were reported in the study's 14-year follow-up.
Monovalent versus Trivalent vaccines
MMR is described as a "trivalent" vaccine, since three viruses are targeted (measles, mumps and rubella). "Monovalent" vaccine targets only one virus, such as measles.
• Wakefield suggested that monovalent vaccines might offer less risk of negative effects, although no evidence exists to support this theory.
• There is evidence that some monovalents may not be as effective as the trivalent vaccines and, in fact, may cause more adverse reactions.
Isn't it more "natural" to spread out exposure to viruses over a period of time -not to expose a child to several viruses at once?
In fact, children are commonly exposed to many different viral illnesses in everyday life, often several within a very short period of time.
• Surprisingly, an early study comparing reactions to monovalent measles vaccine with MMR showed that children receiving MMR had fewer side effects and less respiratory infections in the weeks following vaccination than children receiving monovalent measles immunization.
This suggests that MMR made children more resistant to other infections in the short-term.
Where can I get a monovalent vaccine?
• Monovalent vaccines are no longer available in Canada.
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• They are only available in the United States.
Are there risks in using monovalent vaccine?
Monovalent vaccines are not as well studied as is MMR therefore there is not much safety data.
• The biggest known risk in the use of monovalent measles vaccine is the delay in protection for rubella and mumps, since 6 needles will be required over an unspecified period of time to vaccinate for all three diseases. Children may be over 3 years old before all of these vaccinations are received, making them vulnerable to serious infection in the meantime.
What should parents know about the potentially serious nature of viral infections?
North Americans do not often worry about viruses like measles, mumps and rubella because we feel these diseases are under control. It is through vaccination, however, that developed nations have been able to minimize the effects of these infections. The risk of contagious and potentially dangerous disease increases dramatically when large numbers of children are not vaccinated.
• What is being done to reassure parents of children with autism?
The National Institutes for Health (NIH) in Washington, D.C. is responding to parents' concerns with a lot of research.
• The NIH Internet website contains excellent information for parents, including ongoing research project information and results.
Conclusions and Recommendations for Parents
There are many answers still to be found, but we do know that:
• There is definite evidence that the vaccinations currently given to Canadian children are safe.
• Evidence that early signs of autism are present during infancy, before obvious symptoms are noticed, indicates that the onset of autism occurs well before vaccination.
• The risk that autism is triggered by MMR vaccine is not currently well supported by sound scientific data.
• Failure to immunize constitutes a well-known and extremely high risk for all children.
• All possible efforts must be made to protect children from devastating infectious diseases.
Crucial to this process is ensuring that children receive vaccinations promptly.
Part 2: MERCURY POISONING
If MMR doesn't cause autism, is it Mercury?
Mercury can be derived from thimerosal, which is used in some vaccines as a preservative. In the past few years, it has been claimed that cumulative mercury poisoning from the usual series of childhood immunizations may be an unidentified cause for autism in susceptible children.
This theory has caused further anxiety about vaccines as well as a trend for parents to seek chelation therapy aimed at removing heavy metals like mercury from their child's body, despite the risks and expense of this treatment.
Important Facts about Mercury and Thimerosal
• Canadian DPTP and MMR vaccines do not contain thimerosal. The mercury alarm was raised in the United States, where thimerosal is used in DPTP and other vaccines. If thimerosal/mercury causes autism, it would be reasonable to expect a difference between the number of autism cases in Canada and the U.S., since one population is exposed to cumulative mercury while the other is not. Such a difference has not been seen.
• In Canada, only one vaccine commonly used for infants under 6 months of age contains 
thimerosal -a Hepatitis B (HBV) vaccine (not used in British Columbia
What is Chelation Therapy?
Chelation involves injecting a chemical into the bloodstream that is intended to attach its molecules to particles of toxic substances in the body (e.g., heavy metals). The toxins are then "piggybacked" out of the body when the chemical is excreted in the urine.
Unique Concerns for Parents of Autistic Children
There is a great deal of information available about the relationship between heavy metal poisoning and autism. Chelation therapy is the most frequently recommended treatment. Here is what current evidence tells us:
